Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-1.97	-49.50	-48.54
Graham Fair Price	-8.95	1352.89	1485.84
PEG	127.90	-0.01	< 0.005
Price/Book	-6.95	0.31	0.33
Price/Cash Flow	8.44	-41.57	-45.40
Prices/Earnings	18.91	2.25	-1.89
Price/Sales	35.84	77.07	56.73
Price/FCF	8.44	-41.57	-45.40
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-46.38	-0.57	-0.39
Operating Margin	-51.74	-1.80	-1.19
ROA	-19.84	0.03	-0.03
ROE	-0.04	0.03	-21.75
ROIC	< 0.005	0.01	127.05
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	5.08	-0.61	731.73
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.30	-0.07	77.06
EPS QOQ	-3.46	1.81	-47.82
FCF QOQ	-3.30	-0.05	98.61
Revenue QOQ	-0.23	-0.29	-27.25
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	172.73	227.69	31.82
Days Sales Outstanding (DSO)	126.36	150.99	19.49
Inventory Turnover	0.52	0.40	-24.14
Debt/Capitalization	< 0.005	0.05	452.18
Quick Ratio	0.52	0.43	-17.35
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1492.54	1536.27	2.93
Cash	49.38	37.70	-23.66
Capex	0.00	-0.06	-100.00
Free Cash Flow	-10.95	-11.45	-4.60
Revenue	8.76	6.18	-29.49
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.96	0.77	-19.52
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.77	-6.71	-772.37
Naive Interpretation	Member

06 - Financial Health · Bad

Rating